Search Results for "Triamcinolone Pharmacokinetics Plasma"
Original Source: Intraocular and Systemic Pharmacokinetics of Triamcinolone Acetonide after a Single 40-mg Posterior Subtenon Application.
PURPOSE: To characterize the pharmacokinetics of triamcinolone acetonide (TA) in aqueous, vitreous, and systemic circulation after a single subtenon injection. DESIGN: Prospective interventional case series. PARTICIPANTS: Thirty-six patients (36 eyes) who received a single posterior subtenon injection of TA (40 mg in 0.4 ml). METHODS: Aqueous, vitreous, and blood samples were obtained at 1-hour, 1-day, 3-day, 5-day, 10-day, 14-day, 21-day, and 28-day time points after the posterior subtenon TA injection. At...
Matching Channels
Matching News
Pulsed Plasma Characterization
The performance of the Hiden Analytical family of plasma diagnostic tools is further advanced by integration of onboard timers for real-time pulsed plasma measurement, the fast gating controllable wit...
Pharmacokinetics Parameters of Sunshine Biopharma’s Lead Anti-Cancer Compound Exceed Expectations
Sunshine Biopharma Inc. (OTCBB: SBFM) a development stage pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various f...
Type: Original PaperPurposeFormulate phospho-sulindac (P-S, OXT-328) in a Pluronic hydrogel to be used as a topical anti-inflammatory agent and study its efficacy, safety and pharmacokinetics in an ar...
The AAPS Journal: Pharmacokinetics and Tissue Disposition of Lenalidomide in Mice
Type: Original PaperLenalidomide is a synthetic derivative of thalidomide exhibiting multiple immunomodulatory activities beneficial in the treatment of several hematological malignancies. Murine phar...
Joe Van Ess, a long-time plasma donor in Grandville, Michigan, is one of many individuals around the United States who have made the unselfish commitment to donate their healthy plasma to help save li...
FDA approves Octapharma's human plasma product
FDA approved a BLA from Octapharma AG (Lachen, Switzerland) for Octaplas to manage preoperative or bleeding patients who require replacement of multiple plasma coagulation factors, and to substitute i...
Mcl-1 is essential for the survival of plasma cells
Tarlinton and colleagues show that the antiapoptotic protein Mcl1 is essential for plasma cell survival and is induced by BCMA signaling in bone marrow, but not spleen, plasma cells.
Plasma screens enhanced as disorder strikes
A new study improves our understanding of plasma sources, a state of matter similar to gas in which a certain portion of the particles are ionised and which are used for example in plasma display pane...
Matching PubMed Articles
PURPOSE: To characterize the pharmacokinetics of triamcinolone acetonide (TA) in aqueous, vitreous, and systemic circulation after a single subtenon injection. DESIGN: Prospective interventional case...
Background: To provide an update on the intravitreal use of triamcinolone acetonide. Methods: Review of literature regarding triamcinolone-related research. Results: After the introduction of bevacizu...
In this study, a triamcinolone acetonide-loaded hydrogel was prepared by electron beam irradiation and evaluated for use as a buccal mucoadhesive drug delivery system. A poloxamer was modified to have...
Effects of Itraconazole, Dexamethasone and Naringin on Pharmacokinetics of Nadolol in Rats.
The aim of the present study was to clarify the involvement of P-glycoprotein (P-gp) or organic anion transporting polypeptide (Oatp) 1a5 in the pharmacokinetics of nadolol (NDL), a non-metabolized hy...
Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy.
PURPOSE: The purpose of this study is to report the use of intravitreal triamcinolone for treatment of cancer-associated retinopathy (CAR) refractory to systemic therapy. METHODS: This was a retrospec...
